Introducing HIV Outcomes Italy

HIV Outcomes Italy consists of the following members:

  • Mario Cascio
  • Antonella d’Arminio Monforte
  • Marcello Tavio
  • Lorenzo Badia
  • Antonio Di Biagio
  • Sergio Lo Caputo
  • Claudio Mastroianni
  • ASA ONLUS Massimo Cernuschi
  • Anlaids Bruno Marchini
  • Anna Maria Cattelan
  • Giovanni Guaraldi
  • Lila Massimo Oldrini
  • Cristina Mussini
  • NPS Italia Margherita Errico
  • Plus APS Sandro Mattioli
  • Andrea Antinori

Activities & Milestones

HIV Outcomes Italy was launched in 2020 in partnership with The Bridge Foundation, with the aim to raise awareness among national policymakers, MPs and other relevant stakeholders on the existing challenges of living with HIV. The ultimate goal is to work towards the implementation of HIV Outcomes’ Europe recommendations and vision at national level.


April 2021

A second round of Delphi questionnaire was shared with both community representatives and clinicians.


March 2021

Delphi questionnaire was shared with clinicians and community representatives with the aim to gather information on the current situation in Italy, exploring challenges and barriers to quality of life and identifying possible solutions to address them.

The questionnaire is based on the five recommendations on long-term health, well-being and chronic care for people living with HIV developed by HIV Outcomes Europe in 2017.


February 2021

A first meeting of a focus group gathering clinicians involved in HIV care was convened in February 2021 with the aim of identifying the existing gaps in the way healthcare systems currently address the quality of life of people living with HIV.


January 2021

A first focus group bringing together community-based organisations was organized with the aim of capturing the community perspective on the existing gaps in the way HIV care currently addresses the quality of life of people living with HIV.


December 2020

HIV Outcomes Italy kicked off activities at the end of 2020, with the setup of a group of community representatives and clinicians.

This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.